-
Abstract Number: PB0650
Validation of a New Point-of-Care Platelet Counter
-
Abstract Number: PB0168
Validation of a Non- Sensitive aPTT Reagent for the Presence of Anti-Phospholipid Abs (Lupus Anti-Coagulant)
-
Abstract Number: PB0568
Validation of a Warfarin Dose Prediction Model: A Single Center Retrospective Study
-
Abstract Number: PB1011
Validation of an Algorithm to Identify Hemophilia A Patients in Administrative Database
-
Abstract Number: PB0685
Validation of the Atellica COAG 360 Coagulation Analyzer
-
Abstract Number: PB0692
Validation of the ROTEM PLATELET® Module as an Impedance Platelet Aggregation Test Compared to the Gold Standard Test: Conventional Platelet Aggregation
-
Abstract Number: PB1253
Validity and Reliability of Self-Administered Thai Pediatric Bleeding Questionnaire (TPBQ) Application to Predict Risk of Bleeding in Pediatric Bleeding Disorders
-
Abstract Number: PB1033
Value of Super Microvascular Imaging and Contrast-enhanced Ultrasound in Evaluating the Neovascularization of Synovial Hypertrophy in Hemophilia Joints
-
Abstract Number: PB0622
Variability in Dabigatran and Apixaban trough Concentrations
-
Abstract Number: PB1239
Variability in Diagnosis and Management of Immune Thrombocytopenia in Children: Real Life According to Spanish Pediatricians and Hematologists
-
Abstract Number: PB2430
Variability in Exposure to Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Hospitalised Patients
-
Abstract Number: PB1672
Variability in Platelet Function among Patients with von Willebrand Disease Type 2B (VWD2B): Focus on Patients Historically Diagnosed with Montreal Platelet Syndrome (Historic-MPS)
-
Abstract Number: PB2392
Variability of Management of Peripheral Catheter-Related Upper Extremity Superficial Vein Thrombosis
-
Abstract Number: PB0604
Variable Findings in One-Stage Clotting Assays in a Patient with Waldenstrom’s Macroglobulinaemia
-
Abstract Number: PB1507
Variants in the LLR5 Domain Confer to GPIbα Increased Affinity for VWF: A Novel Case of Platelet-type von Willebrand Disease
-
Abstract Number: PB1446
Variants of GFI1B: Phenotype/Genotype of a Series of 9 New Cases
-
Abstract Number: PB1893
Varied Presentations of TTP
-
Abstract Number: PB2288
Vein Thrombosis after an Osteopathy Session
-
Abstract Number: PB2297
Venous Involvement in Behcet Disease: Clinical Spectrum and Predictive Factors
-
Abstract Number: PB2449
Venous Recanalization after a Thromboembolic Event in a North Afriacan Population
-
Abstract Number: PB2174
Venous Thromboembolic Risk in Ambulatory Cancer Patients: Awareness Needed!
-
Abstract Number: PB2279
Venous Thromboembolism (VTE) Events in Elective and Emergency Orthopaedic Surgery in a Large Teaching Hospital 2011 to 2019
-
Abstract Number: PB2126
Venous Thromboembolism (VTE) Events with Cancer as a Risk Factor in a Teaching Hospital: 2015-2019
-
Abstract Number: PB1294
Venous Thromboembolism (VTE) in Children with Community-acquired Staphylococcus Aureus Bacteremia (CA-SAB) in Children: Risk Factors and Prevalence Study from a Single Pediatric Tertiary Care Center in Argentina
-
Abstract Number: PB2141
Venous Thromboembolism in Patients with Cancer in Palliative Care
-
Abstract Number: PB2372
Venous Thromboembolism in Patients with Renal Transplantation
-
Abstract Number: PB2421
Venous Thromboembolism Profile and Management Differences between Sexes in a RIETE’s Hospital in Brazil
-
Abstract Number: PB2242
Venous Thrombosis-dominant Congenital Dysfibrinogenemia Presenting with Cerebral Venous Sinus Thrombosis
-
Abstract Number: PB/CO07
Venous Thrombotic Complications in Cancer Patients with SARS-CoV-2 Infection: Report from the COVID-19 and Cancer Consortium (CCC19) Registry Analysis
-
Abstract Number: PB1962
Vessel-On-A-Chip Model Revealing Rapid Offset and Onset Mechanisms of Collagen- and Thrombin-Induced Platelet Activation
-
Abstract Number: PB1626
Video Rate, High Contrast Morphological Imaging of Blood Thrombus using Label – Free Coherent Optical Scattering and Interferometry (COSI) Microscopy
-
Abstract Number: PB2374
Visualization of Thrombin Formation on Activated Platelets and Fibrin Formation in Venous Flow Condition
-
Abstract Number: PB1054
Vitamin D Status and Risk of Osteoporosis in Hemophilia Patients
-
Abstract Number: PB1924
Vitamin K Antagonist (VKA) Monitoring Using Point of Care Testing (POCT) in Patients with Antiphospholipid Syndrome (APS)
-
Abstract Number: PB2058
Vitamin K Antagonists Dosing According to Pharmacogenetics
-
Abstract Number: PB0313
VMX-C001 Is a Reversal Agent for FXa-inhibiting DOACs and Displays a Favorable Pharmacokinetic and Pharmacodynamic Profile
-
Abstract Number: PB1546
von Willebrand Disease Combined with Other Coagulation Defects: Experience at a Single Reference Coagulation Laboratory in Iran
-
Abstract Number: PB0502
Von Willebrand Disease Type 1 Is Associated with Number of Rare Nonsynonymous Variants in the VWF Gene
-
Abstract Number: PB0146
Von Willebrand Factor (VWF) Deficiency Leads to Altered Angiogenesis in the Gastrointestinal Tract
-
Abstract Number: OC 01.1
von Willebrand Factor as a Predictor of Mortality and its Target Concentration Dependent Inhibition by BT200 Aptamer in Patients Treated with Potent ADP Receptor Blockers
-
Abstract Number: PB0073
Von Willebrand Factor in Stroke and Non-valvular Atrial Fibrillation Patients
-
Abstract Number: PB0157
von Willebrand Factor Levels and Expression Pattern Are Altered in Response to Aging
-
Abstract Number: PB1552
von Willebrand Factor Propeptide: Useful Diagnostic Add-On to Differentiate von Willebrand Disease Based upon Increased von Willebrand Factor Clearance
-
Abstract Number: PB1592
Von Willebrand’s Disease: A Diagnostic Evaluation Using Current Guidelines
-
Abstract Number: PB2204
VTE and its complications: A Real World View Daryl Pollock, RN, MN CNS Thrombosis/Haemostasis
-
Abstract Number: PB2353
VTE Prophylaxis Performance in a Tertiary and Secondary Level Hospital in Ireland
-
Abstract Number: PB2477
VTE Treatment in Routine Clinical Practice: A Pre-specified Combined Evaluation of XALIA and XALIA-LEA with Additional Analyses of Special Patient Populations
ISTH 2020 Congress
July 12-14, 2020. Virtual Congress.